The Medicines Company to Announce Third Quarter 2019 Financial Results on October 30
October 24 2019 - 4:30PM
Business Wire
The Medicines Company (NASDAQ: MDCO) will host a conference call
and audio webcast on Wednesday, October 30, 2019 at 8:30 a.m. EDT
to discuss its third quarter 2019 financial results and operational
developments.
The conference call may be accessed by telephone as follows:
U.S./Canada:
(877) 407-0312
International:
(201) 389-0899
Conference ID:
13696004
A live audio webcast of the conference call may be accessed in
the Investors section of The Medicines Company website.
A taped replay of the conference call will be available after
the call concludes, and may be accessed by telephone as
follows:
U.S./Canada:
(877) 660-6853
International:
(201) 612-7415
Conference ID:
13696004
An archived webcast will be also be available after the call
concludes.
About The Medicines Company
The Medicines Company (NASDAQ: MDCO) is a biopharmaceutical
company with a singular, relentless focus on addressing the
greatest global healthcare challenge and burden today –
cardiovascular disease. Our purpose is to halt the deadly
progression of atherosclerosis and the cardiovascular risk created
by high levels of LDL cholesterol. The Company is headquartered in
Parsippany, New Jersey. For more information, please visit
www.themedicinescompany.com and follow us on Twitter @MDCONews and
LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20191024005693/en/
Investor Relations Krishna Gorti, M.D. Vice President,
Investor Relations 973 290 6122 krishna.gorti@themedco.com
Media Inquiries Michael Blash Vice President,
Communications 973 290 6100 michael.blash@themedco.com
Medicines (NASDAQ:MDCO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Medicines (NASDAQ:MDCO)
Historical Stock Chart
From Apr 2023 to Apr 2024
